Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Alpha1-adrenergic blockers: current usage considerations.

Domenic A Sica¹

¹Department of Medicine, Section of Clinical Pharmacology and Hypertension, Division of Nephrology, Virginia Commonwealth University, Richmond, VA 23298, USA. dsica@hsc.vcu.edu

Journal of Clinical Hypertension (Greenwich, Conn.)

|December 7, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cardiopulmonary Baroreflex Control of Renal Sympathetic Nerve Activity Is Impaired in Dogs With Left Ventricular Dysfunction.

Journal of cardiac failure·2019

Same author

Does the benefit from treating to lower blood pressure targets vary with age? A systematic review and meta-analysis.

Journal of hypertension·2019

Same author

History and Justification of a National Blood Pressure Measurement Validated Device Listing.

Hypertension (Dallas, Tex. : 1979)·2018

Same author

Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis.

Journal of clinical hypertension (Greenwich, Conn.)·2018

Same author

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution.

JACC. Basic to translational science·2018

Same author

Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis.

Journal of hypertension·2018

Same journal

Antihypertensive Efficacy, Safety, and Adherence After Switching From a Free Combination of Bisoprolol/Metoprolol and Amlodipine to Bisoprolol/Amlodipine FDC Tablets (5/5 mg) in Chinese Patients With Hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2026

Same journal

Blood Pressure Variability in Acute Ischemic Stroke: Current Evidence, Measurement Challenges, and Future Directions.

Journal of clinical hypertension (Greenwich, Conn.)·2026

Same journal

Association of Triglyceride-Glucose Index, Triglyceride/HDL Cholesterol Ratio and Metabolic Score for Insulin Resistance With Asymptomatic Organ Damage in Previously Untreated Patients With Hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2026

Same journal

Letter to the Editor Regarding: "Associations of High-Sensitivity Cardiac Troponin and N-Terminal Pro-B-Type Natriuretic Peptide With Echocardiographic Features in Patients With Hypertension".

Journal of clinical hypertension (Greenwich, Conn.)·2026

Same journal

Relationship of Carotid-Femoral Pulse Wave Velocity and Brachial-Ankle Pulse Wave Velocity With the Risk of New-Onset Cardiovascular Events: A Cohort Study in the Beijing Community-Based Population.

Journal of clinical hypertension (Greenwich, Conn.)·2026

Same journal

Oral Health and Cardiovascular Disease Among Hypertensive Medicated Adults With Uncontrolled Blood Pressure.

Journal of clinical hypertension (Greenwich, Conn.)·2026

See all related articles

Alpha1-adrenergic blockers effectively lower blood pressure, comparable to other classes, and uniquely improve lipid profiles. However, they can cause side effects like orthostatic hypotension and may be less effective with dose escalation.

Area of Science:

Pharmacology
Cardiovascular Medicine
Urology

Background:

Alpha1-adrenergic-blocking drugs are a recognized class of antihypertensive agents.
These drugs offer benefits beyond blood pressure reduction, including lipid profile improvement and treatment for benign prostatic hypertrophy.

Purpose of the Study:

To summarize the efficacy and side effect profile of alpha1-adrenergic-blocking drugs.
To highlight their unique benefits and potential limitations in clinical practice.

Main Methods:

Review of existing literature on alpha1-adrenergic-blocking drugs.
Analysis of their effects on blood pressure, lipid profiles, and benign prostatic hypertrophy.
Evaluation of common side effects and contraindications.

Related Experiment Videos

Main Results:

Alpha1-adrenergic blockers reduce systolic and diastolic pressures by 8%-10% in the upright position.
They are the only antihypertensive class to improve plasma lipid profiles.
Potential side effects include orthostatic hypotension, dizziness, headache, and drowsiness. Dose escalation can lead to renal sodium retention and volume expansion, attenuating efficacy.

Conclusions:

Alpha1-adrenergic blockers are effective antihypertensives with unique lipid-improving properties, valuable for benign prostatic hypertrophy.
Careful patient selection and monitoring are necessary due to potential side effects like orthostatic hypotension and the impact of dose escalation on efficacy.